Evidence map›Paper›PMID 34465271›Full record

ArticleCell cycle (Georgetown, Tex.)2021

CircLNPEP promotes the progression of ovarian cancer through regulating miR-876-3p/ WNT5A axis.

Wenwen Wang, Weiwei Zhang, Hongjun Guo, Danxia Chu, Ruitao Zhang, Ruixia Guo

RetractedOpen access · bronzeAbstract readRetracted Publication
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wenwen WangDepartment of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Weiwei ZhangDepartment of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Hongjun GuoDepartment of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Danxia ChuDepartment of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Ruitao ZhangDepartment of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Ruixia GuoDepartment of Gynaecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
First Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CircRNA LNPEP has been shown to promote the development of hepatocellular carcinoma, but its function in ovarian cancer (OC) remains unclear. The Kaplan-Meier method was used to analyze the clinical significance of circLNPEP expression in OC patients. The stability of circLNPEP was detected by actinomycin D and RNase R treatment. The correlations between miR-876-3p and two genes (circLNPEP and WNT5A) were predicted by bioinformatics analysis and confirmed by dual-luciferase reporter assay. Expressions of circLNPEP, miR-876-3p, and WNT5A were determined by qRT-PCR and western blot. The effect of circLNPEP/miR-876-3p/WNT5A axis on viability, proliferation, migration, and invasion, and angiogenesis of cells was determined by cell function experiment and rescue experiment. Xenograft tumor mice were constructed for

Indexed as

Liver NeoplasmsMicroRNAsOvarian NeoplasmsAnimalsCell Line, TumorCell MovementCell ProliferationHumansMiceWnt-5a ProteinMicroRNAsMIRN876 microRNA, humanWnt-5a ProteinWNT5A protein, humanCirclnpepepithelial mesenchymal transitionmiR-876-3povarian cancerWNT5A

Identifiers

PMID34465271
PMCPMC8565828
OpenAlexW3196943654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.